An experimental vaccine proves promising for preventing the contraction of HIV infection.
Press Release Service – Wired PR News – An experimental vaccine has shown promise in the prevention of HIV infection. As reported by the Associated Press (AP), researchers have seen success for the first time in a vaccine used to prevent the infection that causes AIDS.
As noted by the AP, the experimental vaccine has been shown to cuts risks of HIV infection by over 31 percent in a clinical trial based in Thailand. Mitchell Warren, AIDS Vaccine Advocacy Coalition Executive Director, who is not connected to the study, is quoted in the report as releasing the statement of the findings, “Today marks a historic milestone… It will take time and resources to fully analyze and understand the data, but there is little doubt that this finding will energize and redirect the AIDS vaccine field.”
As further noted in the report, details about the massive study are expected to be presented next month at a conference in Paris.
WiredPRNews.com – The latest in Health News
Photo Credit: Wikipedia User C. Goldsmith
USGov-HHS-CDC
